Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 441-447

  Dudley, Mark E ^a   Roopenian, Derry C ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA; TUMOR REJECTION;

EID: 0029788299     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.441     Document Type: Article

References (28)

1. Boon, T., J.C. Cerottinin, B. Van den Eynde, P. van der Bruggen, and A. Van Pel. 1994. Tumor antigens recognized by T lymphocytes. Annu. Rev. Immunol. 12:337-365.
2. Prehn, R.T., and J.M. Main. 1957. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18: 769-778.
3. Klein, G., H.O. Sjogren, E. Klein, and K.E. Hellstrom. 1960. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 20:1561-1572.
4. Basombrio, M.A. 1970. Search for common antigenicity among twenty-five sarcomas induced by methylcholanthrene. Cancer Res. 30:2458-2462.
5. Shu, S., T. Chou, and S.A. Rosenberg. 1987. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. J. Immunol. 139:295-304.
6. Chou, T., and S. Shu, 1987. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma. J. Immunol. 139:2103-2109.
7. + T-cell lines. Cancer Res. 55:5648-5655.
8. Robbins, P.F., M. el Gamil, Y. Kawakami, E. Stevens, J.R. Yannelli, and S.A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy [published erratum appears in Cancer Res. 1994. 54:3952]. Cancer Res. 54:3124-3126.
9. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Indentification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6462.
10. Van Der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van Den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
11. Kitajima, T., M. Iwashiro, K. Kuribayashi, and S. Imamura. 1994. Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse. Cancer Immunol. Immunother. 38:372-378.
12. Urban, J.L., M.L. Kripke, and H. Schreiber. 1986. Stepwise immunologic selection of antigenic variants during tumor growth. J. Immunol. 137:3036-3041.
13. Wortzel, R.D., C. Philipps, and H. Schreiber. 1983. Multiple tumour-specific antigens expressed on a single tumour cell. Nature (Lond.). 304:165-167.
14. Lill, N.L., M.J. Tevethia, W.G., Hendrickson, and S.S. Tevethia. 1992. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for point mutations within sequences encoding CTL recognition epitopes. J. Exp. Med. 176:449-457.
15. + anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen. Cancer Res. 54:4424-4429.
16. Maryanski, J., and T. Boon. 1982. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones. Eur. J. Immunol. 12: 406-412.
17. Urban, J.L., and H. Schreiber. 1992. Tumor Antigens. Annu. Rev. Immunol. 10:617-644.
18. Dudley, M.E., J.P. Sundberg, and D.C. Roopenian. 1995. Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methlycholanthrene in interspecific mice. Oncogene. 11:517-524.
19. Dye, E.S., R.J. North, and C.D. Mills. 1981. Mechanisms of anti-tumor action of Corynebacterium parvum: potentiated tumor-specific immunity and its therapeutic limitations. J. Exp. Med. 154:609-620.
20. Roopenian, D.C., C.G. Orosz, and F.H.J.I. Bach. 1984. Responses against single minor histocompatibility antigens. II. Analysis of cloned helper T cells. J. Immunol. 132:1080-1084.
21. King, T.R., G.J. Christianson, M.J. Mitchell, C.E. Bishop, D. Scott, I. Ehrmann, E. Simpson, E.M. Eicher, and D.C. Roopenian. 1994. Deletion mapping by immunoselection against the H-Y histocompatibility antigen further resolves the Sxra region of the mouse Y chromosome and reveals complexity of the Hya locus. Genomics. 24:159-168.
22. Zuberi, A.R., M.E. Dudley, G.J. Christianson, and D.C. Roopenian. 1994. Gene mapping in a murine cell line by immunoselection with cytotoxic T lymphocytes. Genomics. 19: 273-279.
23. Wunderlich, J., and G. Shearer. 1992. In vitro assays for mouse lymphocyte function. In Current Protocols in Immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Marguiles, E.M. Shevach, and W. Strober, editors. John Wiley & Sons, New York. 3.11.1-3.11.15.
24. Barth, R.J., Jr., S.N. Bock, J.J. Mule, and S.A. Rosenberg. 1990. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. J. Immunol. 144:1531-1537.
25. Restifo, N.P., Y. Kawakami, F. Marincola, P. Shamamian, A. Taggarse, F. Esquivel, and S.A. Rosenberg. 1993. Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. J. Immunother. 14:182-190.
26. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P.G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340-347.
27. + T cells to an antigen that no longer serves as a target. J. Exp. Med. 178:933-940.
28. Ramarathinam, L., S. Sarma, M. Maric, M. Zhao, G. Yang, L. Chen, and Y. Liu. 1995. Multiple lineages of tumors express a common tumor antigen, P1A, but they are not cross-protected. J. Immunol. 155:5323-5329.